A Phase 3, Multi-center, Randomized, Double-Blind

Project: Research project

Description

A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients with Epidermolysis Bullosa
StatusActive
Effective start/end date4/20/164/30/20

Funding

  • SCIODERM, INC.

Fingerprint

Epidermolysis Bullosa
Placebos
Safety